Back to Search
Start Over
Personnel exposure in labelling and administration of 177Lu-DOTA-D-Phe1-Tyr3-octreotide
- Source :
- Nuclear Medicine Communications; October 2011, Vol. 32 Issue: 10 p947-953, 7p
- Publication Year :
- 2011
-
Abstract
- The introduction of peptide receptor radionuclide therapy, mainly performed with 90Y and 177Lu-labelled somatostatin analogues, has widened the therapeutic horizon of nuclear medicine.
Details
- Language :
- English
- ISSN :
- 01433636 and 14735628
- Volume :
- 32
- Issue :
- 10
- Database :
- Supplemental Index
- Journal :
- Nuclear Medicine Communications
- Publication Type :
- Periodical
- Accession number :
- ejs48834211
- Full Text :
- https://doi.org/10.1097/MNM.0b013e328349fd60